Results 221 to 230 of about 69,426 (314)

The safety of herbal medicines in low- and middle-income countries (LMICs): current landscape and promoting the pharmacovigilance practices. [PDF]

J Pharm Policy Pract
Khan MAA, Khalid M, Malik O.
europepmc   +1 more source

Medicines, pharmacovigilance, and the importance of undertaking comprehensive assessments and regular medicine reviews

, 2017
Patricia Dunning
openalex   +1 more source

From Barns to Bushes: Exploring the ECOFF‐Based Non‐Wild‐Type Status of Campylobacter spp. in Pets, Livestock, Synanthropic Birds and Wild Animals in Northwestern Italy

Zoonoses and Public Health, Volume 73, Issue 1, Page 30-44, February 2026.
ABSTRACT Introduction Antimicrobial resistance (AMR) poses a significant threat to both humans and animals. Zoonotic bacteria, such as Campylobacter, contribute to human infections and the spread of AMR, particularly through livestock, pets and wildlife. We investigated the prevalence, distribution and EUCAST ECOFF‐based wild‐type (WT) vs.
Aitor Garcia‐Vozmediano, Barbara Moroni, Cristina Marra, Monica Pitti, Giuliano Garofolo, Francesca Marotta, Roberta Di Romualdo, Simona Zoppi, Giuseppe Ru   +8 more
wiley   +1 more source

Real-World Data on Severe Cutaneous Adverse Reactions to Drugs. [PDF]

Pharmaceuticals (Basel)
Zyryanov S, Terehina E, Butranova O, Asetskaya I, Polivanov V, Yudin A.   +5 more
europepmc   +1 more source

Functional, Pharmacogenomic, and Immune Landscapes of Long Non‐Coding RNAs in Cancer

Advanced Science, Volume 13, Issue 6, 30 January 2026.
A systematic analysis of 33 cancer types reveals widespread associations between lncRNAs and cancer pathways, drug responses, immune features, and immunotherapy outcomes. The study identifies key lncRNAs linked to therapeutic response and adverse events and introduces PILNC, an interactive web portal for exploring the functional, pharmacogenomic, and ...
Runhao Wang, Mei Luo, Yuan Liu, Jingwen Yang, Yamei Chen, Chengxuan Chen, Lifei Ma, Stephanie Ding, James Wengler, Yong Zang, Bora Lim, Wenbo Li, Liuqing Yang, Chunru Lin, Lixia Diao, Leng Han   +15 more
wiley   +1 more source

Evaluating the effectiveness of AI-enhanced "One Body, Two Wings" pharmacovigilance models in China: a nationwide survey on medication safety and risk management. [PDF]

Front Health Serv
Yang J, Sun Y, Li F, Wei Q, Wei J, Zhang Y.   +5 more
europepmc   +1 more source

Lymphopenia associated with sphingosine 1-phosphate receptor modulators (S1PRMs) in multiple sclerosis: analysis of European pharmacovigilance data [PDF]

Nunzia Balzano, Raffaella Di Napoli, Federica Fraenza, Daniele Di Giulio Cesare, Ornella Moreggia, Mirko Cardillo, Cristina Scavone, Giorgia Teresa Maniscalco, Annalisa Capuano, Liberata Sportiello   +9 more
openalex   +1 more source

Life‐Threatening Agranulocytosis Induced by Sinomenine Hydrochloride in Chronic Kidney Disease: A Case Report and Literature Review

Clinical Case Reports, Volume 14, Issue 1, January 2026.
ABSTRACT Sinomenine, derived from Sinomenium acutum, is widely used in inflammatory diseases. However, its risk of inducing agranulocytosis is not widely appreciated. We report a life‐threatening case in a 40‐year‐old woman with chronic kidney disease (CKD; baseline estimated glomerular filtration rate [eGFR] as low as 36 mL/min/1.73 m2) who developed ...
Ping Xin, Ruoyan Liu, Yu Zhang, Bin Fu
wiley   +1 more source

In utero exposure to medications and congenital eye anomalies. [PDF]

BMJ Open Ophthalmol
Mairesse R, Lepetit M, Dubucs C, Cifuentes EA, Damase-Michel C, Lacroix I.   +5 more
europepmc   +1 more source

Pharmacovigilance during ibrutinib therapy for chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL) in routine clinical practice

, 2016
Heidi D. Finnes, Kari G. Chaffee, Timothy G. Call, Wei Ding, Saad S. Kenderian, Deborah A. Bowen, Michael Conte, Kristen McCullough, Julianna A. Merten, Gabriel Bartoo, Matthew D. Smith, José F. Leis, Asher Chanan‐Khan, Susan M. Schwager, Susan L. Slager, Neil E. Kay, Tait D. Shanafelt, Sameer A. Parikh   +17 more
openalex   +2 more sources